story of the week
SER-109: Oral Microbiome Therapy for Recurrent C. difficile Infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
N. Engl. J. Med 2022 Jan 20;386(3)220-229, P Feuerstadt, TJ Louie, B Lashner, EEL Wang, L Diao, JA Bryant, M Sims, CS Kraft, SH Cohen, CS Berenson, LY Korman, CB Ford, KD Litcofsky, MJ Lombardo, JR Wortman, H Wu, JG Auniņš, CWJ McChalicher, JA Winkler, BH McGovern, M Trucksis, MR Henn, L von MoltkeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.